152 related articles for article (PubMed ID: 21735387)
1. WITHDRAWN: Conjugate vaccines for preventing meningococcal C meningitis and septicaemia.
Conterno LO; da Silva Filho CR; Ruggeberg JU; Heath PT
Cochrane Database Syst Rev; 2011 Jul; 2011(7):CD001834. PubMed ID: 21735387
[TBL] [Abstract][Full Text] [Related]
2. Conjugate vaccines for preventing meningococcal C meningitis and septicaemia.
Conterno LO; Silva Filho CR; Rüggeberg JU; Heath PT
Cochrane Database Syst Rev; 2006 Jul; (3):CD001834. PubMed ID: 16855979
[TBL] [Abstract][Full Text] [Related]
3. Polysaccharide vaccines for preventing serogroup A meningococcal meningitis.
Patel M; Lee CK
Cochrane Database Syst Rev; 2005 Jan; (1):CD001093. PubMed ID: 15674874
[TBL] [Abstract][Full Text] [Related]
4. Meningococcal conjugate vaccines: efficacy and new combinations.
Sáfadi MA; Barros AP
J Pediatr (Rio J); 2006 Jul; 82(3 Suppl):S35-44. PubMed ID: 16826310
[TBL] [Abstract][Full Text] [Related]
5. Quadrivalent meningococcal conjugate vaccines.
Pace D; Pollard AJ; Messonier NE
Vaccine; 2009 Jun; 27 Suppl 2():B30-41. PubMed ID: 19477560
[TBL] [Abstract][Full Text] [Related]
6. A critical appraisal of the recommendations for the use of meningococcal conjugate vaccines.
Sáfadi MA; Berezin EN; Oselka GW
J Pediatr (Rio J); 2012 May; 88(3):195-202. PubMed ID: 22622596
[TBL] [Abstract][Full Text] [Related]
7. Polysaccharide vaccines for preventing serogroup A meningococcal meningitis.
Patel M; Lee CK
Cochrane Database Syst Rev; 2001; (3):CD001093. PubMed ID: 11686976
[TBL] [Abstract][Full Text] [Related]
8. Update on the use of meningococcal serogroup C CRM₁₉₇-conjugate vaccine (Meningitec) against meningitis.
Badahdah AM; Rashid H; Khatami A
Expert Rev Vaccines; 2016; 15(1):9-29. PubMed ID: 26560735
[TBL] [Abstract][Full Text] [Related]
9. Meningococcal serogroup C serum and salivary antibody responses to meningococcal quadrivalent conjugate vaccine in Saudi Arabian adolescents previously vaccinated with bivalent and quadrivalent meningococcal polysaccharide vaccine.
Khalil M; Al-Mazrou Y; Findlow H; Chadha H; Bosch Castells V; Oster P; Borrow R
Vaccine; 2014 Sep; 32(43):5715-21. PubMed ID: 25151042
[TBL] [Abstract][Full Text] [Related]
10. Meningococcal conjugate vaccines.
Zimmer SM; Stephens DS
Expert Opin Pharmacother; 2004 Apr; 5(4):855-63. PubMed ID: 15102568
[TBL] [Abstract][Full Text] [Related]
11. Long-term protection in children with meningococcal C conjugate vaccination: lessons learned.
Borrow R; Miller E
Expert Rev Vaccines; 2006 Dec; 5(6):851-7. PubMed ID: 17184222
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of meningococcal serogroup C vaccine programmes.
Borrow R; Abad R; Trotter C; van der Klis FR; Vazquez JA
Vaccine; 2013 Sep; 31(41):4477-86. PubMed ID: 23933336
[TBL] [Abstract][Full Text] [Related]
13. A randomized study comparing the safety and immunogenicity of a conjugate vaccine combination containing meningococcal group C and pneumococcal capsular polysaccharide--CRM197 with a meningococcal group C conjugate vaccine in healthy infants: challenge phase.
Riddell A; Buttery JP; McVernon J; Chantler T; Lane L; Bowen-Morris J; Diggle L; Morris R; Lockhart S; Pollard AJ; Cartwright K; Moxon ER
Vaccine; 2007 May; 25(19):3906-12. PubMed ID: 17368663
[TBL] [Abstract][Full Text] [Related]
14. Polysaccharide vaccines for preventing serogroup A meningococcal meningitis.
Patel M
Cochrane Database Syst Rev; 2000; (2):CD001093. PubMed ID: 10796590
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) administered concomitantly with the meningococcal serogroup B (4CMenB) vaccine in infants: A post-hoc analysis in a phase 3b, randomised, controlled trial.
Safadi MAP; Martinon-Torres F; Weckx LY; Moreira ED; da Fonseca Lima EJ; Willemsen A; Toneatto D; Habib MA; Borys D
Vaccine; 2019 Aug; 37(35):4858-4863. PubMed ID: 31327652
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers.
McVernon J; Nolan T; Richmond P; Reynolds G; Nissen M; Lambert SB; Marshall H; Papa T; Rehm C
Pediatr Infect Dis J; 2012 Jan; 31(1):e15-23. PubMed ID: 22094636
[TBL] [Abstract][Full Text] [Related]
17. Meningococcal vaccine evolution.
Bona G; Guidi C
J Prev Med Hyg; 2012 Sep; 53(3):131-5. PubMed ID: 23362617
[TBL] [Abstract][Full Text] [Related]
18. Meningococcal C conjugate vaccine effectiveness before and during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C/cc11, Tuscany, Italy.
Pezzotti P; Miglietta A; Neri A; Fazio C; Vacca P; Voller F; Rezza G; Stefanelli P
Vaccine; 2018 Jul; 36(29):4222-4227. PubMed ID: 29895504
[TBL] [Abstract][Full Text] [Related]
19. Recent developments in Neisseria meningitidis group A conjugate vaccines.
Frasch CE
Expert Opin Biol Ther; 2005 Feb; 5(2):273-80. PubMed ID: 15757388
[TBL] [Abstract][Full Text] [Related]
20. Meningococcal quadrivalent (serogroups A, C, W135, and Y) conjugate vaccine (Menveo(®)): profile report.
Deeks ED
Paediatr Drugs; 2012 Feb; 14(1):63-5. PubMed ID: 22149552
[No Abstract] [Full Text] [Related]
[Next] [New Search]
